Merck continues to boost oncology pipeline through acquisitions
Drug Discovery World
JANUARY 15, 2024
“At Merck, we continue to enhance our oncology pipeline through strategic acquisitions that complement our current portfolio and advance breakthrough science to help address the needs of people with cancer worldwide,” said Dr Dean Li, President, Merck Research Laboratories.
Let's personalize your content